Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 122, Issue -, Pages -Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2019.109694
Keywords
N-6-methyladenosine; RNA methylation; Human cancers; m(6)A; Cancer therapy
Funding
- National Key RD Plan Project [2017YFA0106700]
- Chongqing Basic Research and Frontier Exploration Key Issues [cstc2017jcyjAX0421]
Ask authors/readers for more resources
M(6)A is the most prevalent modification among epigenetics. M(6)A occurs on different sites of RNA and exerts important functions in specific circumstances, such as mRNA splicing, stability, nuclear export, translation or damage response. Different aspects of the concrete machinery of m(6)A modification have been studied, including its writing, erasing and reading capabilities. The molecular and biological functions of the m(6)A modification and enzymes, as well as their functions in different cancers have been substantially published. The present review summarizes these findings and provides clear description of the problems involved. The probable roles of m(6)A modification may acts on other cancers, suggesting that it may be a treatment target for these cancers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available